Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
  Pharmaceutical Technology Europe E-Alert
 
September 11, 2009
IN THIS ISSUE
EU electronic submissions
FDA timelines met
Controlled release generics
EC backs nanotech
More...
Click Here

EMEA mandates electronic submissions by 1 January 2010
The European Medicines Agency (EMEA) has issued a reminder that the Electronic Common Technical Document (e-CTD) format will be mandatory for marketing authorization applications for medicinal products for human use from 1 January 2010. More...

Most firms meet postmarketing study timelines
More than 80% of pharmaceutical and biologics companies are completing their postmarketing studies and regulatory obligations in a timely manner, according to the FDA. More...

Controlled-release formulations targeted by generics companies
Generic drug companies are increasingly viewing the development of controlled-release formulations as a way of obtaining a competitive edge, according to a report published by Espicom Business Intelligence in August 2009. More...

EC backs nanotechnology with 1 billion euros
The European Commission (EC) has made 1 billion euros available for new projects involving micro and nanotechnology. More...

Pfizer takes $2.3 billion hit
Pfizer will pay $2.3 billion to settle the investigation with the US Department of Justice regarding the off-label promotion of Bextra. More...

Encap's deal to target colonic drug delivery
Encap Drug Delivery (UK) has licensed a coating technology that targets the release of drugs to the colon. More...

Join PTE on LinkedIn!
Join Pharmaceutical Technology Europe's group on LinkedIn. More...

FDA seeks data for Sentinel Initiative
The FDA plans to begin collecting information for its Sentinel Initiative, according to the Federal Register announcement. More...

Dainippon Sumitomo Pharma to acquire Sepracor
In a move designed to increase its position in North America, Dainippon Sumitomo Pharma (DSP, Japan) has agreed to acquire the specialty pharmaceutical company Sepracor (MA, USA) for $2.6 billion. More...

Event profile
World Drug Manufacturing
2–4 December 2009
Germany
How will drug manufacturing respond to the current global recession? The current economic crisis affects everyone, however the drug manufacturing industry can continue to thrive through cost of goods reduction, increasing productivity and promoting efficiency. World Drug Manufacturing 2009 is the only conference and networking event this year to give you the strategies to continue to be successful through the challenging times ahead.
Read more...

Property Measurement and Testing of Powders for Pharmaceutical / Neutraceutical Production

29 September 2009
UK
A one-day seminar hosted by the University of Greenwich focusing on the practicalities of achieving and maintaining production of high quality products whilst minimising the generation of out-of specification materials. The day represents an opportunity to familiarise with some of the latest scientific techniques for improving formulation and processing performance.
Read more...

Recruitment Profile
Biology Technician — Production, Council of Europe

European Directorate for the Quality of Medicines & HealthCare

The Council of Europe, based in Strasbourg, France, is a political organisation founded in 1949 to promote greater unity among its member States. Today its membership numbers 47 States across Europe, working together to promote democracy, human rights and the rule of law and to develop common responses to political, social, cultural and legal challenges.
Read more...

Key Topic Updates
September events
QbD/PAT Conference 2009 (Germany)
Property Measurement and Testing of Powders for Pharmaceutical / Neutraceutical Production (UK)
The Control of Biotechnology Products (UK)
Submit your event
 
Latest blog posts
A RX for health reform
FDA’s recent actions against illegal prescription drug flow
More than a salary survey
More blog posts
 
Latest articles
The combination drugs debate: Incompatibility problems can be overcome
Embryonic stem cells: the moral dilemma of patentability and funding
Belgium: Will its enviable geographic position continue to ensure success in pharma?
More latest articles
Click Here

Key Topic Updates

Survey
FDA recently outlined six steps the agency will take to increase enforcement of its regulations. Are these steps…
  What the agency needs to achieve its mission of improving public health 58%
  Not going far enough to protect consumers 18%
  Unnecessary — FDA's processes work fine as is 24%

This week we would like to know...

What impediments, if any, do you encounter in implementing green chemistry/engineering practices?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing [email protected]or by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.